BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1507 related articles for article (PubMed ID: 18094443)

  • 1. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of Hymenoptera venom allergy in Eastern Spain.
    Fernandez J; Soriano V; Mayorga L; Mayor M
    Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy.
    Sturm GJ; Heinemann A; Schuster C; Wiednig M; Groselj-Strele A; Sturm EM; Aberer W
    Allergy; 2007 Aug; 62(8):884-9. PubMed ID: 17620065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by sting- induced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms.
    Kochuyt AM; Van Hoeyveld EM; Stevens EA
    Clin Exp Allergy; 2005 Apr; 35(4):441-7. PubMed ID: 15836751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Hymenoptera venom allergy.
    Biló BM; Rueff F; Mosbech H; Bonifazi F; Oude-Elberink JN;
    Allergy; 2005 Nov; 60(11):1339-49. PubMed ID: 16197464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R; Glück J; Jawor B; Rogala B
    Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic reactions during maintenance immunotherapy with honey bee venom.
    Bousquet J; Ménardo JL; Velasquez G; Michel FB
    Ann Allergy; 1988 Jul; 61(1):63-8. PubMed ID: 3389573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients.
    Goldberg A; Confino-Cohen R; Mekori YA
    Ann Allergy Asthma Immunol; 1995 Jul; 75(1):30-2. PubMed ID: 7621057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom.
    Stritzke AI; Eng PA
    Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid venom immunotherapy is safe for routine use in the treatment of patients with Hymenoptera anaphylaxis.
    Bernstein JA; Kagen SL; Bernstein DI; Bernstein IL
    Ann Allergy; 1994 Nov; 73(5):423-8. PubMed ID: 7978535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy control of specific hymenoptera venom allergy].
    Aust W; Wichmann G; Dietz A
    Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stinging insect allergy.
    Pence HL
    Prim Care; 1979 Sep; 6(3):587-96. PubMed ID: 392579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
    Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastocytosis and insect venom allergy.
    Bonadonna P; Zanotti R; Müller U
    Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.